AbbVie (NYSE:ABBV) announces that
it is working with global health authorities, including the FDA, CDC,
BARDA, NIH and Chinese officials, to determine if HIV med Kaletra/Aluvia
(lopinavir/ritonavir) is effective in treating COVID-19, the current
coronavirus outbreak.
It has donated Aluvia to the Chinese government
for experimental use but apparently does not have access to clinical
information thus far.
The company is “closely monitoring” manufacturing
and supply chain resources worldwide to ensure supply for HIV patients
as well as COVID-19 use.
Shares down 6% premarket on light volume as most biotech and biopharma players are in the red before the open.
https://seekingalpha.com/news/3549715-abbvie-hiv-drug-being-investigated-potential-covidminus-19-treatment
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.